Prognostic value of baseline body composition parameters from 18F-FDG PET/CT in angioimmunoblastic T-cell lymphoma patients.

IF 2.4 3区 医学 Q2 HEMATOLOGY
Huanyu Gong, Jingjie Shang, Jianyong Li, Chongyang Ding, Hao Xu, Lijun Tang, Yong Cheng
{"title":"Prognostic value of baseline body composition parameters from <sup>18</sup>F-FDG PET/CT in angioimmunoblastic T-cell lymphoma patients.","authors":"Huanyu Gong, Jingjie Shang, Jianyong Li, Chongyang Ding, Hao Xu, Lijun Tang, Yong Cheng","doi":"10.1007/s00277-025-06562-0","DOIUrl":null,"url":null,"abstract":"<p><p>This retrospective study investigated preliminarily the prognostic value of body composition parameters derived from baseline <sup>18</sup>F-FDG PET/CT in angioimmunoblastic T-cell lymphoma (AITL) patients. We included 94 treatment-naïve AITL patients diagnosed by histopathology. Based on the axial CT images of the third lumbar vertebra, the areas of skeletal muscle (SM), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) were semi-automatically delineated and standardized to finally obtain SM index (SMI), VAT index (VATI), and SAT index (SATI). Body composition density characterized by CT attenuation was obtained, including SM density (SMD), VAT density (VATD), and SAT density (SATD). Besides, the maximum standardized uptake value (SUVmax), total metabolic tumor volume (TMTV), and total lesion glycolysis (TLG) were also calculated. Endpoints included progression-free survival (PFS) and overall survival (OS). Survival curves and Cox regression analysis were performed‌‌.Of 94 AITL patients(mean age:63.4 ± 9.7 years,67% men), 65 progressed and 55 died[median follow-up: 27.5 (10.5-45.7) months].High baseline C-reactive protein level [hazard ratio (HR) = 2.47, 95%CI: 1.37-4.45, p = 0.003), low SMD (HR = 2.18, 95%CI:1.29-3.69, p = 0.003), high SATD (HR = 1.92, 95%CI: 1.05-3.54, p = 0.035), and low VATI (HR = 1.95, 95%CI: 1.12-3.38, p = 0.018) were independent risk factors for poor PFS. AITL score>2(HR = 2.90, 95%CI: 1.59-5.29, p < 0.001), sarcopenia(HR = 1.78, 95%CI: 1.01-3.12,p = 0.045), low VATI(HR = 2.24,95%CI: 1.27-3.95,p = 0.005), and high TMTV(HR = 2.46, 95%CI: 1.37-4.40, p = 0.003) may serve as independent risk factors for poor OS. In conclusion, in addition to conventional TMTV, body composition parameters derived from baseline <sup>18</sup>F-FDG PET/CT may offer preliminary prognostic value for AITL patients.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-025-06562-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This retrospective study investigated preliminarily the prognostic value of body composition parameters derived from baseline 18F-FDG PET/CT in angioimmunoblastic T-cell lymphoma (AITL) patients. We included 94 treatment-naïve AITL patients diagnosed by histopathology. Based on the axial CT images of the third lumbar vertebra, the areas of skeletal muscle (SM), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) were semi-automatically delineated and standardized to finally obtain SM index (SMI), VAT index (VATI), and SAT index (SATI). Body composition density characterized by CT attenuation was obtained, including SM density (SMD), VAT density (VATD), and SAT density (SATD). Besides, the maximum standardized uptake value (SUVmax), total metabolic tumor volume (TMTV), and total lesion glycolysis (TLG) were also calculated. Endpoints included progression-free survival (PFS) and overall survival (OS). Survival curves and Cox regression analysis were performed‌‌.Of 94 AITL patients(mean age:63.4 ± 9.7 years,67% men), 65 progressed and 55 died[median follow-up: 27.5 (10.5-45.7) months].High baseline C-reactive protein level [hazard ratio (HR) = 2.47, 95%CI: 1.37-4.45, p = 0.003), low SMD (HR = 2.18, 95%CI:1.29-3.69, p = 0.003), high SATD (HR = 1.92, 95%CI: 1.05-3.54, p = 0.035), and low VATI (HR = 1.95, 95%CI: 1.12-3.38, p = 0.018) were independent risk factors for poor PFS. AITL score>2(HR = 2.90, 95%CI: 1.59-5.29, p < 0.001), sarcopenia(HR = 1.78, 95%CI: 1.01-3.12,p = 0.045), low VATI(HR = 2.24,95%CI: 1.27-3.95,p = 0.005), and high TMTV(HR = 2.46, 95%CI: 1.37-4.40, p = 0.003) may serve as independent risk factors for poor OS. In conclusion, in addition to conventional TMTV, body composition parameters derived from baseline 18F-FDG PET/CT may offer preliminary prognostic value for AITL patients.

18F-FDG PET/CT基线体成分参数对血管免疫母细胞t细胞淋巴瘤患者的预后价值
本回顾性研究初步探讨了18F-FDG PET/CT基线体成分参数对血管免疫母细胞t细胞淋巴瘤(AITL)患者预后的价值。我们纳入94例经组织病理学诊断的treatment-naïve AITL患者。基于第三腰椎轴向CT图像,对骨骼肌(SM)、内脏脂肪组织(VAT)和皮下脂肪组织(SAT)区域进行半自动圈定和标准化,最终得到SM指数(SMI)、VAT指数(VATI)和SAT指数(SATI)。得到以CT衰减为特征的体成分密度,包括SM密度(SMD)、VAT密度(VATD)和SAT密度(SATD)。并计算最大标准化摄取值(SUVmax)、肿瘤总代谢体积(TMTV)、病变总糖酵解(TLG)。终点包括无进展生存期(PFS)和总生存期(OS)。进行生存曲线和Cox回归分析。94例AITL患者(平均年龄:63.4±9.7岁,男性67%),65例进展,55例死亡[中位随访:27.5(10.5-45.7)个月]。高基线c -反应蛋白水平[危险比(HR) = 2.47, 95%CI: 1.37 ~ 4.45, p = 0.003]、低SMD (HR = 2.18, 95%CI:1.29 ~ 3.69, p = 0.003)、高SATD (HR = 1.92, 95%CI: 1.05 ~ 3.54, p = 0.035)和低VATI (HR = 1.95, 95%CI: 1.12 ~ 3.38, p = 0.018)是不良PFS的独立危险因素。AITL评分bbbb2 (HR = 2.90, 95%CI: 1.59-5.29, p 18F-FDG PET/CT可为AITL患者提供初步预后价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of Hematology
Annals of Hematology 医学-血液学
CiteScore
5.60
自引率
2.90%
发文量
304
审稿时长
2 months
期刊介绍: Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信